Orikami
Orikami provides a medical AI platform called KRANE™ that enables the development, validation, and management of medical algorithms and digital biomarkers. The infrastructure integrates clinical datasets, sensor data, and patient-reported outcomes to support regulated MedTech software development and Software as a Medical Device (SaMD). The company serves medical researchers, MedTech developers, and life-science organizations looking to transform real-world health data into actionable clinical insights.
Visit websiteNijmegen, Netherlands
Healthtech
Artificial Intelligence
Medtech
Life Sciences
Funding summary
- Total raised
- €600K
- Funding rounds
- 1
Investors in Orikami
Investors on record for Orikami. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Orikami?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors